Aims/hypothesis A meta-analysis was performed to assess the association of C47T (rs4880) (also called Val16Ala) polymorphism in SOD2 gene with reduced risk of diabetes mellitus, including type 1 and type 2 diabetes, and diabetic microvascular complications (DMI) including diabetic nephropathy, diabetic retinopathy and diabetic polyneuropathy. Methods A comprehensive search was conducted to identify all case-control or cohort design studies of the abovementioned associations. The fixed or random effect pooled measure was selected on the basis of homogeneity test among studies. Heterogeneity among studies was evaluated using the I 2 . Meta-regression and the 'leave one out' sensitive analysis of Patsopoulos et al. were used to explore potential sources of between-study heterogeneity. Publication bias was estimated using modified Egger's linear regression test as proposed by Harbord et al. Results Seventeen articles were included. After excluding articles that deviated from Hardy-Weinberg equilibrium in cases and/or in controls, and were also the key contributors to between-study heterogeneity, the meta-analysis showed a significant association of the C allele with reduced risk of DMI in dominant (OR 0.788, 95% CI 0.680-0.914), recessive (OR 0.808, 95% CI 0.685-0.953) and codominant (OR 0.828, 95% CI 0.751-0.913) models. It also showed a significant association with reduced risk of diabetic nephropathy in the dominant model (OR 0.801,, and reduced risk of diabetic retinopathy in the dominant (OR 0.601, 95% CI 0.423-0.855), recessive (OR 0.548, 95% CI 0.369-0.814) and codominant (OR 0.651, 95% CI 0.517-0.820) models. Conclusions/interpretation The meta-analysis suggested that C allele of C47T polymorphism in SOD2 gene has protective effects on risk of DMI, diabetic nephropathy and diabetic retinopathy. This risk needs to be confirmed by further studies.
Introduction
Oxidative stress induced by superoxide anion plays a key role in the initiation as well as progression of diabetes mellitus [1] and diabetic microvascular complications (DMI) [2] . Superoxide dismutase (SOD) 2 (also known as manganese superoxide dismutase [MnSOD] ) is an essential defender against mitochondrial superoxide radicals among antioxidative enzymes [3] . The T to C nucleotide polymorphism (rs4880) (previously called C47T) [4] , which is located in exon 2 of SOD2 gene and results in the amino acid substitution of valine with alanine at position 16 of the protein (Val16Ala), is considered the most interesting of several polymorphisms in SOD2 gene, because C allele instead of T allele results in more efficient transport of SOD2 into the mitochondrial matrix [5] , which can increase the ability to neutralise superoxide radicals. Since Chistyakov et al first showed the significant association between C47T polymorphism in SOD2 gene and risk of diabetic polyneuropathy (DPN), and no significant association with type 1 diabetes risk [6] , the associations of this polymorphism with diabetes mellitus, including type 1 and type 2 diabetes, and DMI including diabetic nephropathy, diabetic retinopathy and DPN have been investigated. However, the published results are controversial. Hence we conducted a metaanalysis to: (1) assess the effect of C47T polymorphism in SOD2 gene on risk of diabetes mellitus and of DMI including diabetic nephropathy, diabetic retinopathy and DPN; (2) evaluate the potential heterogeneity among studies; and (3) explore any potential publication bias. . The search strategy used the following keywords: 'diabetes' and 'C47T', 'Val16Ala', 'MnSOD', 'SOD2', 'manganese superoxide dismutase', 'superoxide dismutase', 'polymorphism', 'mut*' and 'varia*'. Additional studies not captured by our database searches were identified by reviewing the bibliographies of relevant articles as well as those of relevant studies.
Methods

Search strategy
Inclusion criteria All identified studies were carefully reviewed independently by two investigators to determine whether an individual study was eligible for inclusion in this meta-analysis. The inclusion criteria were as follows: (1) case-control or cohort study published as an original study to evaluate the association between C47T (Val16Ala) polymorphism in SOD2 gene and risk of diabetes mellitus and of DMI including diabetic nephropathy, diabetic retinopathy and DPN; (2) numbers in case and control groups or exposed and unexposed groups reported for each genotype, or data provided from which numbers could be calculated; (3) case and control groups in case-control study or exposed and unexposed groups in cohort study unrelated and drawn from the same temporally and geographically defined underlying population. If the two investigators disagreed about the eligibility of an article, it was resolved by consensus with a third reviewer.
Data extraction Data were independently extracted by two investigators who reached a consensus on all of the items. The most recent and complete article was chosen, if a study had been published more than once. Information extracted from each study was as follows: publication year, name of first author, country, ethnic origin of the studied population, number in case (exposed) and control (unexposed) groups, genotype and allele distributions, mean age, male sex percentage in case (exposed) and control (unexposed) groups.
Statistical analysis
We used χ 2 analysis with exact probability to test departure from Hardy-Weinberg equilibrium (HWE) for the C47T genotype distribution of SOD2 gene in case and control groups. Pooled measure was calculated as the inverse variance-weighted mean of the logarithm of OR with 95% CI to assess the strength of association between C47T polymorphism in SOD2 gene and risk of diabetes mellitus and of DMI including diabetic nephropathy, diabetic retinopathy and DPN for dominant (CC+TC vs TT), recessive (CC vs TC+TT) and codominant (C vs T) models, respectively. The I 2 of Higgins and Thompson was used to assess heterogeneity among studies [7] . I 2 describes the proportion of total variation attributable to between-study heterogeneity as opposed to random error or chance. In the presence of substantial heterogeneity (I 2 >50%) [8] , the DerSimonian and Laird random effect model (REM) was adopted as the pooling method; otherwise, the fixed effect model (FEM) was used as the pooling method. Metaregression with restricted maximum likelihood estimation was performed to assess the potentially important covariates exerting substantial impact on between-study heterogeneity. The 'leave one out' sensitive analysis [9] was carried out using I 2 >50% as the criteria to evaluate the key studies with substantial impact on between-study heterogeneity. Publication bias was estimated using modified Egger's linear regression test, as proposed by Harbord et al [10] . An analysis of influence was conducted [11] , which describes how robust the pooled estimator is to removal of individual studies. An individual study is suspected of excessive influence, if the point estimate of its omitted analysis lies outside the 95% CI of the combined analysis. All statistical analyses were performed with STATA version 9.2 (Stata Corporation, College Station, TX, USA). All reported probabilities (p values) were two-sided, with p<0.05 considered statistically significant.
Results
Characteristics of studies We found 17 published articles [6, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] with 31 outcomes eligible for this meta-analysis on the relation of C47T polymorphism in SOD2 gene to diabetes mellitus and DMI including diabetic nephropathy, diabetic retinopathy and DPN. All 17 eligible studies were case-control designs. General characteristics, the C47T allele and genotype distributions in the published articles included in this meta-analysis are showed in Tables 1 and 2 .
Quantitative synthesis Results of pooled analysis are summarised in detail in Table 3 . This meta-analysis showed a significant protective effect of C allele on risk of diabetes mellitus, including type 1 and type 2 diabetes, in the recessive (REM OR 0.509, 95% CI 0.300-0.861) and codominant (REM OR 0.672, 95% CI 0.459-0.984) models, but this was only marginally significant in the dominant model (REM OR 0.626, 95% CI 0.391-1.002). However, no significant association was found between C allele and reduced risk of diabetes mellitus after excluding articles that deviated from HWE in cases and/or in controls for dominant (REM OR 0.594, 95% CI 0.325-1.086), recessive (REM OR 0.430, 95% CI 0.162-1.141) and codominant (REM OR 0.637, 95% CI 0.371-1.093) models.
The C allele was found to be significantly associated with a reduced risk of diabetic nephropathy in the dominant (REM OR 0.734, 95% CI 0.559-0.964) model, with marginal significance in codominant (REM OR 0.820, 95% CI 0.670-1.003) models, and no significant association in the recessive model (REM OR 0.948, 95% CI 0.725-1.239). After exclusion of articles deviating from HWE in cases and/or in controls, the associations in the above-mentioned inherited models were not significant.
With regard to diabetic retinopathy, no significant association with the C allele was found in dominant (REM OR 0.685, 95% CI 0.444-1.057), recessive (REM OR 0.773, 95% CI 0.408-1.463) and codominant (REM OR 0.759, 95% CI 0.503-1.147) models. After exclusion of articles deviating from HWE in cases and/or in controls, the associations in the above-mentioned inherited models remained non-significant.
The meta-analysis also showed a significant association between the C allele and reduced risk of DPN in dominant (FEM OR 0.197, 95% CI 0.101-0.383), recessive (FEM OR 0.367, 95% CI 0.246-0.549) and codominant (FEM OR 0.506, 95% CI 0.397-0.644) models. However, all relevant articles regarding the association between C47T polymorphism and risk of DPN deviated from HWE in cases and/or in controls.
In addition, when we combined diabetic nephropathy, diabetic retinopathy and DPN into overall DMI, we found a significant effect of C allele on reduced risk of DMI in dominant (REM OR 0.649, 95% CI 0.520-0.809), recessive (REM OR 0.733, 95% CI 0.573-0.940) and codominant (REM OR 0.739, 95% CI 0.631-0.866) models. However, no significant association was found between C allele and reduced risk of DMI after excluding articles that deviated from HWE in cases and/or in controls with regard to the above-mentioned inherited models.
Sources of heterogeneity and sensitive analysis As seen in Table 3 , before the 'leave one out' sensitive analysis [9] , strong evidence of heterogeneity among studies was demonstrated in the above-mentioned inherited models for risk of diabetes mellitus, DMI, diabetic nephropathy and diabetic retinopathy, with the exception in the recessive model for diabetic nephropathy risk. No significant heterogeneity among studies was found in the above-mentioned inherited models for DPN risk.
After excluding the articles deviating from HWE in cases and/or in controls, univariate meta-regression analysis, with the covariates publication year, ethnicity (categorised as Europeans, East Asians, South Asians and North Africans), sex (ratio of males in per cent in case group to that in control group), age (ratio of mean age in case group to that in control group) and sample size, showed that no covariates had a significant impact on between-study heterogeneity.
The key contributors of the articles to between-study heterogeneity assessed by the 'leave one out' sensitive analysis [9] are presented as 'articles excluded' in Table 3 .
After exclusion of articles that deviated from HWE in cases and/or in controls, and were the key contributors to between-study heterogeneity, the meta-analysis showed a significant association of the C allele with reduced risk of DMI in dominant (OR 0.788, 95% CI 0.680-0.914) (Fig. 1) , recessive (OR 0.808, 95% CI 0.685-0.953) and codominant (OR 0.828, 95% CI 0.751-0.913) models. It also showed a significant association of the C allele with reduced risk of diabetic nephropathy in the dominant model (OR 0.801, 95% CI 0.664-0.967) (Fig. 2) , as well as with reduced risk of diabetic retinopathy in dominant (OR 0.601, 95% CI 0.423-0.855), recessive (OR 0.548, 95% CI 0.369-0.814) and codominant (OR 0.651, 95% CI 0.517-0.820) models.
Influence analysis After excluding articles that deviated from HWE in cases and/or in controls, and were the key contributors to between-study heterogeneity, no individual study was found to have excessive influence on the pooled effect in the above-mentioned inherited models with regard to diabetes mellitus, DMI, diabetic nephropathy and diabetic retinopathy, with the exception of one study [19] on reduced risk of diabetes mellitus in the recessive model (OR of this study was 0.701, with 95% CI for pooled effect of 0.757-1.452).
Publication bias evaluation After excluding articles that deviated from HWE in cases and/or in controls, and were the key contributors to between-study heterogeneity, no significant publication bias was detected in the abovementioned inherited models for diabetes mellitus, DMI, The SOD2 encoded by the T allele, which disrupts the alpha-helix structure of the targeting sequence, is retained in the mitochondrial inner membrane and induces 30 to 40% lower activity and oxidative stress level. Chistyakov et al [6] first showed the significant protective effect of C47T polymorphism in SOD2 gene on DPN risk in 82 DPN cases and 84 non-DPN controls in type 1 diabetes mellitus patients, but no association with risk of type 1 diabetes mellitus was found in 166 type 1 diabetes mellitus cases and 88 normal controls in a Russian population. Nevertheless, results of subsequent studies about the effect of this polymorphism on risk of diabetes mellitus, including type 1 and type 2 diabetes, and of DMI including diabetic nephropathy, diabetic retinopathy and DPN were conflicting. Because of the above-mentioned inconsistent results from relatively small studies underpowered to detect the effect, a meta-analysis is the appropriate approach to obtain a more definitive conclusion regarding the role of SOD2 gene C47T polymorphism on risk of diabetes mellitus and DMI including diabetic nephropathy, diabetic retinopathy and DPN. Our meta-analysis, of 17 published articles [6, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] with 31 outcomes from different ethnic origins, allowed a much greater possibility of reaching reasonably strong conclusions.
As mentioned in one paper [31] , between-study heterogeneity is common in meta-analysis for genetic association studies. Our meta-analysis also showed significant between-study heterogeneity in most of the inherited models regarding diabetes mellitus, DMI, diabetic nephrop- Fig. 1 athy and diabetic retinopathy. An indeterminate number of characteristics that vary among studies could be the cause of between-study heterogeneity, e.g. design quality, population stratification, characteristics of the sample, noncomparable measure of genotyping, variation of the covariate, deviation from HWE in some studies, etc. Thus we used meta-regression and 'leave one out' sensitive analysis [9] , which aims to reduce between-study heterogeneity and explore the potential important causes of between-study heterogeneity for both covariates and studies. Our meta-analysis of the studies that were in HWE in cases and controls did not identify any of the aforementioned covariates as being an important contributor to between-study heterogeneity. When, after the 'leave one out' sensitive analysis using I 2 >50% as the criteria, we performed data analysis on the studies that were in HWE in cases and controls, our results showed that the C allele of C47T polymorphism in SOD2 gene had a significant effect on reduced risk of DMI, diabetic nephropathy and diabetic retinopathy, but not of diabetes mellitus.
According to another article [32] and the SNP database at the NIH (www.ncbi.nlm.nih.gov/projects/SNP/snp_ref. cgi?rs=4880, accessed 24 September 2010), the C allele frequency in the Asian population is significantly lower than in most European populations. Such heterogeneous genetic backgrounds might be, in part, responsible for the heterogeneity of effect on the disease across the ethnicity, even though we could not detect this in our meta-analysis. Diabetes mellitus and DMI including diabetic nephropathy, diabetic retinopathy and DPN, have a complex aetiology and pathophysiology generated by the combined effects of genes and environment factors. Although ethnicity, sex and age were not found to be important sources of disease-effect heterogeneity across the studies in this meta-analysis, other genetic and environment variables, as well as their possible interaction, may well be potential contributors to this disease-effect unconformity. In this respect, the lack of relevant study-level covariates in the reported articles precluded a more robust assessment of sources of this heterogeneity. Other possibilities related to disease-effect diversity, such as variations in design quality, variations in genotyping, etc. could not be ruled out.
In this meta-analysis, we could not find any significant publication bias in the above-mentioned inherited models for diabetes mellitus, including type 1 and type 2 diabetes, DMI, diabetic nephropathy and diabetic retinopathy, this may be due to the small number of studies in those metaanalyses, especially for diabetic retinopathy risk evaluation.
In conclusion, this meta-analysis suggested that the C allele of C47T polymorphism in SOD2 gene had significant protective effects on risk of DMI, diabetic nephropathy and diabetic retinopathy. Since potential biases and confounders could not be ruled out completely in this meta-analysis, further studies are needed to confirm these results. 
